| abstract |
FIELD: immunology.SUBSTANCE: disclosed is an antibody or antigen-binding fragment thereof against GITR, a nucleic acid, an expression vector, a method for producing a host cell, a host cell. Also disclosed is a method of producing an antibody or antigen-binding fragment thereof, pharmaceutical compositions. Invention also discloses a method of inhibiting GITR biological activity, a method of treating, use of an antibody or its antigen-binding fragment.EFFECT: present invention can find further application in therapy of cancer mediated by GITR.60 cl, 33 dwg, 10 tbl, 23 ex |